Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

22nd Century (XXII) Gains from Sales and Divestitures (2019 - 2024)

22nd Century's Gains from Sales and Divestitures history spans 6 years, with the latest figure at $2.8 million for Q4 2024.

  • For Q4 2024, Gains from Sales and Divestitures rose 4000.0% year-over-year to $2.8 million; the TTM value through Dec 2024 reached $2.8 million, up 4000.0%, while the annual FY2024 figure was $2.8 million, 4000.0% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2024 was $2.8 million at 22nd Century, down from $370.9 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $370.9 million in Q3 2024 and bottomed at $25000.0 in Q2 2023.
  • The 5-year median for Gains from Sales and Divestitures is $491000.0 (2020), against an average of $22.7 million.
  • The largest annual shift saw Gains from Sales and Divestitures plummeted 92.67% in 2023 before it soared 4000.0% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $325000.0 in 2020, then skyrocketed by 410.77% to $1.7 million in 2021, then tumbled by 90.72% to $154000.0 in 2022, then plummeted by 55.19% to $69000.0 in 2023, then skyrocketed by 4000.0% to $2.8 million in 2024.
  • Per Business Quant, the three most recent readings for XXII's Gains from Sales and Divestitures are $2.8 million (Q4 2024), $370.9 million (Q3 2024), and $4.2 million (Q1 2024).